Early-onset cancers are rising globally among adults under 50, driving earlier screening, expanded genomic testing, fertility-focused care, and greater attention to lifestyle-related risk factors.

A nationwide Medicaid analysis reveals persistent schizophrenia care gaps, with poor medication adherence driving high emergency and hospitalization rates, highlighting urgent needs for integrated, proactive care.

Daraxonrasib significantly improves survival, disease control, and quality of life in metastatic pancreatic cancer, marking a major advance in targeted second-line treatment options.

AI-powered imaging tools are enhancing lung cancer risk assessment by identifying high-risk patients earlier, expanding screening opportunities, and supporting more equitable, personalized detection strategies.

Adjunctive glucocorticoids may improve outcomes in hospitalized community-acquired pneumonia, offering a low-cost, scalable strategy to reduce mortality and strengthen care in resource-limited settings.

Bariatric surgery is evolving into a long-term obesity management strategy, emphasizing continuous medical, nutritional, and behavioral support to improve outcomes and reduce weight regain.

FDA approval of a phase 3 trial for the iSCIB1+ melanoma vaccine advances personalized cancer treatment, offering potential survival benefits for patients with advanced disease.

Denosumab may improve survival and reduce skeletal complications in lung cancer patients with bone metastases, supporting more comprehensive and effective oncology care.

An AI model accurately detects heart disease using routine clinical data, expanding diagnostic access, supporting earlier treatment, and improving care in resource-limited hospitals.

Multi-thermic machine perfusion enhances organ preservation by controlling temperature and perfusion, improving viability, reducing injury, extending storage times, and increasing transplant opportunities.